Core Viewpoint - The company, JianKai Technology (688356.SH), forecasts a significant increase in net profit for the year 2025, projecting a net profit attributable to shareholders of the parent company between 60 million to 66 million yuan, representing a year-on-year increase of 30.16 million to 36.16 million yuan, or an increase of 101.09% to 121.20% compared to the previous year [1] Financial Performance - The company expects a year-on-year revenue growth of 38.71% for the year 2025 [1] - The net profit attributable to shareholders of the parent company is projected to increase by 101.09% to 121.20% year-on-year [1] - The net profit attributable to shareholders of the parent company, excluding non-recurring gains and losses, is expected to increase by 131.01% to 156.68% year-on-year [1] Growth Drivers - The anticipated growth in orders and corresponding profit is primarily driven by the sales ramp-up of products launched by downstream overseas new drug clients [1]
键凯科技发预增,预计2025年度归母净利润同比增加101.09%至121.20%